Ribolife-B (06938) opened its IPO at HK$57.97–57.97, raising about HK$bn

• MechanismMechanism B: no clawback mechanism
• Entry FeeHK$11,594.00
• Public Offer Lots13,744 lots
• Public Offer AmountHK$159M
• Cornerstone Share46.5%
• GreenshoeYes
• SponsorChina International Capital Corporation Hong Kong Securities Limited, Citigroup Global Markets Asia Limited
• Stabilizing ManagerChina International Capital Corporation Hong Kong Securities Limited

Source Ribolife-B